Invitrogen launches Stealth RNAi human kinase collection for use in medical screening

By Angela McDaniels

Seattle, Nov. 9 - Invitrogen Corp. said it has released its Stealth RNAi human kinase collection.

Stealth RNAi is a modified RNA duplex that includes an Invitrogen algorithm and advanced specificity search that significantly minimize false-positive results when performing medical screening, the company said.

"Accurate RNAi design - and more importantly, specificity - is on everyone's mind right now," research and development director Peter Welch said in a company press release.

Invitrogen is also releasing other gene family collections and finishing synthesis on the Stealth RNAi human essential druggable genome collection, which should be available in early 2006.

The druggable genome collection will include a set of druggable targets that will enable researchers to save time and costs by performing focused medical screens, the company said.

Invitrogen is a biotechnology company based in Carlsbad, Calif.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.